Phreesia, Inc. (PHR)
| Market Cap | 1.66B |
| Revenue (ttm) | 280.91M |
| Net Income (ttm) | -176.15M |
| Shares Out | 53.36M |
| EPS (ttm) | -3.36 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 369,520 |
| Open | 31.95 |
| Previous Close | 32.23 |
| Day's Range | 30.96 - 32.54 |
| 52-Week Range | 13.19 - 40.00 |
| Beta | 0.65 |
| Analysts | Buy |
| Price Target | 39.49 (+27.02%) |
| Earnings Date | Mar 22, 2023 |
About PHR
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and ... [Read more]
Financial Performance
In 2023, Phreesia's revenue was $280.91 million, an increase of 31.74% compared to the previous year's $213.23 million. Losses were -$176.15 million, 49.1% more than in 2022.
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for PHR stock is "Buy." The 12-month stock price forecast is $39.49, which is an increase of 27.02% from the latest price.
News
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 7.69% and 2.56%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Phreesia Announces Fourth Quarter Fiscal 2023 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2023. "The...
Phreesia Announces Chief Financial Officer Transition
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia's Chief Financial Offic...
Phreesia Named as One of the Achievers 50 Most Engaged Workplaces® of 2023
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named as one of the 2023 Achievers 50 Most Engaged Workplaces®.
Phreesia's Alexandra Beneville Named One of MM+M's ‘Women to Watch' for 2023
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that MM+M has named Alexandra Beneville, Vice President, Life Sciences Content Strategy, to its Women to Watch class of 2023.
Phreesia's Dan Nathan Named as a Top Software CTO of 2023
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is proud to announce that Dan Nathan, the company's Chief Technology Officer, has been named as one of the Top 25 Software CTOs of 2023.
What Makes Phreesia (PHR) a New Buy Stock
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Phreesia (PHR) Soars 6.1%: Is Further Upside Left in the Stock?
Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength do...
Phreesia Sets Release Date for Fiscal Fourth Quarter 2023 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter 2023 financial results after the close of market trading on ...
Phreesia Included in 2023 Bloomberg Gender-Equality Index for the Third Consecutive Year
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is joining 483 other companies as a member of the 2023 Bloomberg Gender-Equality Index (GEI). This r...
Phreesia and the Ad Council Partnership Drives Strong Engagement Across 3 Public Health Campaigns
WILMINGTON, Del. & NEW YORK--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, along with the Ad Council, a nonprofit organization at the forefront of driving change th...
Phreesia Life Sciences Named One of MM+M's “Best Places to Work 2022”
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that for the second year in a row, the healthcare marketing industry trade pu...
Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 13.64% and 2.73%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
Phreesia Announces Third Quarter Fiscal 2023 Results
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the third quarter ended October 31, 2022.
Phreesia's Sara DiNardo Selected as a Top Woman Leader in SaaS
WILIMINGTON, Del.--(BUSINESS WIRE)--Phreesia is proud to announce that Sara DiNardo, the company's Vice President of Client Solutions, has been named to The Software Report's list of the Top 50 Wome...
Phreesia Sets Release Date for Fiscal Third Quarter 2023 Results
RALEIGH, N.C.
Can Phreesia (PHR) Climb 26% to Reach the Level Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 25.7% in Phreesia (PHR). While the effectiveness of this highly sought-after metric is questionable, the positi...
Phreesia Names Alexandra Beneville Vice President of Life Sciences Content Strategy
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has named Alexandra Beneville as Vice President of Life Sciences Content Strategy. Beneville officiall...
Phreesia's Zeeshan Butt Named to NQF's MAP Clinician Workgroup
WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Qualit...
Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates
Phreesia (PHR) delivered earnings and revenue surprises of 10.10% and 3.04%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Phreesia Announces Fiscal Second Quarter 2023 Results
RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2022. "I am extremely proud of o...
Phreesia Sets Release Date for Fiscal Second Quarter 2023 Results
RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2023 financial results after the close of market trading on Wedne...
Phreesia Named to The Software Report's “Top 100 Software Companies of 2022”
RALEIGH, N.C.--(BUSINESS WIRE)--Phreesia is pleased to announce that it has been named to The Software Report's list of “The Top 100 Software Companies of 2022.” The annual award recognizes the best c...
Here's Why Phreesia (PHR) Is a Great 'Buy the Bottom' Stock Now
After losing some value lately, a hammer chart pattern has been formed for Phreesia (PHR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisio...
Wall Street Analysts See a 38% Upside in Phreesia (PHR): Can the Stock Really Move This High?
The mean of analysts' price targets for Phreesia (PHR) points to a 37.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts...